SDSandoz Group AG SDZNY · OTC
$92.17 -0.88% (-$0.82)
- Market cap
- $40.2B
- Enterprise value
- $44.2B
- P/E
- 43.8x
- Forward P/E
- 22.2x
- PEG
- 0.0x
- P/S
- 3.6x
- P/FCF
- 49.7x
- EV/EBITDA
- 25.8x
- ROIC
- 8.2%
- Bruto marža
- 47.0%
- Neto marža
- 8.2%
- Dividend yield
- 1.10%
- Payout ratio
- 48.1%
- Neto dolg/EBITDA
- 2.3x
- Beta
- 0.49
- Free float
- 96.2%
O podjetju
Sandoz Group AG is a Swiss pharmaceutical company specializing in the production of generic drugs and biosimilar products. Founded in 1886, it is now a part of the Novartis group. Sandoz is one of the global leaders in generics, producing drugs that are identical to original products but more affordable. The company focuses on areas such as oncology, cardiovascular diseases, neurology, and infections. Sandoz is known for its innovation in biotechnology, providing high-quality, safe, and affordable treatments to patients worldwide.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard Saynor
Employees
23,000
Headquarters
Basel
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke